Expert Opinion on Drug Safety, Volume 14, Issue 5 (2015)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 14, Issue 5 (2015)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Original Research

Article
From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability
Gemma Caterina Maria Rossi MD, Luigia Scudeller MD, Teresa Rolle MD, Gian Maria Pasinetti MD & Paolo Emilio Bianchi MD
Pages: 619-623
Published online: 10 Mar 2015
AbstractforFrom benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability | Full Text | References | PDF (156.8 KB)
  • 337 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Feedback for patients reporting adverse drug reactions; satisfaction and expectations
Leàn Rolfes PharmD, Florence van Hunsel PharmD PhD, Kees van Grootheest MD PhD & Eugène van Puijenbroek MD PhD
Pages: 625-632
Published online: 12 Mar 2015
AbstractforFeedback for patients reporting adverse drug reactions; satisfaction and expectations | Full Text | References | PDF (367.1 KB) | Supplemental
  • 172 Views
  • 9 CrossRef citations
  • 0Altmetric

Review

Review
Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children
Alan G Magee, Sukeshi Makhecha & Siân Bentley
Pages: 633-642
Published online: 07 Mar 2015
AbstractforRisk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children | Full Text | References | PDF (399.4 KB)
  • 251 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
Tolerance of the newborn to antiretroviral drug exposure in utero
Jeanne Sibiude MD PhD, Josiane Warszawski MD PhD & Stéphane Blanche MD
Pages: 643-654
Published online: 01 Mar 2015
AbstractforTolerance of the newborn to antiretroviral drug exposure in utero | Full Text | References | PDF (425.6 KB)
  • 160 Views
  • 10 CrossRef citations
  • 0Altmetric
Review
Therapy-related myelodysplastic syndrome
Myrna Candelaria (Clinical Researcher, Hematologist and Medical Oncologist) MD PhD & Alfonso Dueñas-Gonzalez (Clinical Researcher, Medical Oncologist) MD PhD
Pages: 655-665
Published online: 12 Feb 2015
AbstractforTherapy-related myelodysplastic syndrome | Full Text | References | PDF (268.5 KB)
  • 660 Views
  • 8 CrossRef citations
  • 0Altmetric
Review
Drug safety and tolerability in prophylactic migraine treatment
László Vécsei (Member of the Hungarian Academy of Sciences) MD PhD DSc, Zsófia Majláth (Resident in Clinical Neurology) MD, Délia Szok (Associate Professor of Clinical Neurology) MD PhD, Anett Csáti (Resident in Clinical Neurology) MD PhD & János Tajti (Associate Professor of Clinical Neurology) (Head of the Department of Neurology) MD PhD
Pages: 667-681
Published online: 13 Feb 2015
AbstractforDrug safety and tolerability in prophylactic migraine treatment | Full Text | References | PDF (595.2 KB)
  • 793 Views
  • 41 CrossRef citations
  • 0Altmetric
Review
Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation
Giacomo Zoppellaro, Serena Granziera, Seena Padayattil Jose, Gentian Denas, Alessia Bracco, Sabino Iliceto & Vittorio Pengo
Pages: 683-695
Published online: 24 Mar 2015
AbstractforMinimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation | Full Text | References | PDF (310.2 KB)
  • 386 Views
  • 9 CrossRef citations
  • 0Altmetric
Review
Safety of human papillomavirus vaccines: a review
Michela Stillo, Paloma Carrillo Santisteve & Pier Luigi Lopalco
Pages: 697-712
Published online: 18 Feb 2015
AbstractforSafety of human papillomavirus vaccines: a review | Full Text | References | PDF (303.8 KB)
  • 9681 Views
  • 53 CrossRef citations
  • 0Altmetric
Open Access
Review
Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection
Atefeh Jafari, Hossein Khalili (Professor of Clinical Pharmacy) , Mandana Izadpanah & Simin Dashti-Khavidaki
Pages: 713-731
Published online: 26 Mar 2015
AbstractforSafely treating hepatitis C in patients with HIV or hepatitis B virus coinfection | Full Text | References | PDF (290.7 KB)
  • 282 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Is there really a link between benzodiazepine use and the risk of dementia?
Sophie Billioti de Gage (PhD Student) PharmD, Antoine Pariente (Professor) & Bernard Bégaud (Professor)
Pages: 733-747
Published online: 18 Feb 2015
AbstractforIs there really a link between benzodiazepine use and the risk of dementia? | Full Text | References | PDF (263.4 KB) | Supplemental
  • 1937 Views
  • 65 CrossRef citations
  • 0Altmetric

Drug Safety Evaluation

Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis
Athina Papadopoulou MD, Ludwig Kappos MD & Till Sprenger (Professor) MD
Pages: 749-759
Published online: 17 Feb 2015
AbstractforSafety of teriflunomide for the management of relapsing-remitting multiple sclerosis | Full Text | References | PDF (299.3 KB)
  • 800 Views
  • 13 CrossRef citations
  • 0Altmetric
Safety of IPX066, an extended release carbidopa–levodopa formulation, for the treatment of Parkinson’s disease
Meir Kestenbaum (Movement Disorders Fellow) MD & Stanley Fahn (Director Emeritus) MD
Pages: 761-767
Published online: 19 Feb 2015
AbstractforSafety of IPX066, an extended release carbidopa–levodopa formulation, for the treatment of Parkinson’s disease | Full Text | References | PDF (232.6 KB)
  • 382 Views
  • 7 CrossRef citations
  • 0Altmetric
The safety of istradefylline for the treatment of Parkinson’s disease
Thomas Müller MD
Pages: 769-775
Published online: 13 Feb 2015
AbstractforThe safety of istradefylline for the treatment of Parkinson’s disease | Full Text | References | PDF (264.1 KB)
  • 447 Views
  • 17 CrossRef citations
  • 0Altmetric
Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review
Alain Didier (Professor) MD & Brigitte Bons MD
Pages: 777-788
Published online: 03 Mar 2015
AbstractforSafety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review | Full Text | References | PDF (421.8 KB) | Supplemental
  • 1885 Views
  • 36 CrossRef citations
  • 0Altmetric
Free Access

Further Readings

Related articles
Page: 1
Published online: 21 Apr 2015
CitationforRelated articles | Full Text | PDF (87.7 KB)
  • 23 Views
  • 3 CrossRef citations
  • 0Altmetric

Key Paper Evaluation

Combination therapy for patients with uncontrolled type 2 diabetes mellitus: adding empagliflozin to pioglitazone or pioglitazone plus metformin
Evaluation of Kovacs CS, Seshiah V, Swallow R, et al. Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial. Diabetes Obes Metab 2014;16:147-158
Thomas Blevins MD
Pages: 789-793
Published online: 19 Mar 2015
AbstractforCombination therapy for patients with uncontrolled type 2 diabetes mellitus: adding empagliflozin to pioglitazone or pioglitazone plus metformin | Full Text | References | PDF (217 KB)
  • 531 Views
  • 5 CrossRef citations
  • 0Altmetric

Explore articles